Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
International Journal for Parasitology: Drugs and Drug Resistance is Scopus-indexed (Q1, CiteScore 5.8), WoS SCIE, DOAJ. Published by Elsevier Ltd.
Checked against the index lists dated .
ISSN 2211-3207Verify ISSN ↗
Publisher: Elsevier Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Parasitology | 14 / 82 | 83rd | Q1 |
| Infectious Diseases | 94 / 361 | 74th | Q2 |
| Pharmacology (medical) | 74 / 278 | 73rd | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2011–present, best quartile Q1, CiteScore 5.8.
International Journal for Parasitology: Drugs and Drug Resistance is Q1 in Parasitology (rank 14 of 82), Q2 in Infectious Diseases (rank 94 of 361) and Q2 in Pharmacology (medical) (rank 74 of 278), by CiteScore 2025.
International Journal for Parasitology: Drugs and Drug Resistance is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.8, which places it in quartile Q1 at the 83rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.797, quartile Q1, with an H-index of 59.
The publisher lists an article processing charge of about US$2,700 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
International Journal for Parasitology: Drugs and Drug Resistance is published by Elsevier Ltd. Its ISSN is 2211-3207.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
International Journal for Parasitology: Drugs and Drug Resistance has an h-index of 69 and a 2-year mean of 3.95 citations per paper (OpenAlex). Its Scopus CiteScore is 5.8, quartile Q1. On 2-year citations it ranks #7 of 80 Scopus journals in Parasitology.
International Journal for Parasitology: Drugs and Drug Resistance published 56 papers in 2025; its busiest recent year was 2018 with 71. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2024–2026), authors are most often from China (18.5%), Australia (11%) and United States (10.3%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.